Evidence map›Paper›PMID 29959347›Full record

Trial reportScientific reports2018

The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set.

Nebojša Mujović, Milan Marinković, Nebojša Marković, Vera Vučićević, Gregory Y H Lip, T Jared Bunch, Tatjana S Potpara

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Pooled it
  2. Trial
  3. Optimized workflow for pentaspline PFA and its impact on PVI durability: evidence from systematic remapping.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Impact of ABO blood type on the risk of atrial fibrillation recurrence after catheter ablation.American heart journal plus : cardiology research and practice · 2024
    Article
  8. Prognostic implication of early recurrence after cryoballoon ablation in patients with atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  9. Article
  10. Re-recognize early recurrence of persistent atrial fibrillation.Frontiers in cardiovascular medicine · 2023
    Article
  11. Article
  12. Association between early recurrences of atrial tachyarrhythmias and long-term outcomes in patients after repeat atrial fibrillation ablation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2022
    Article
  13. Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nebojša MujovićCardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia. nmujovic@gmail.com.
Milan MarinkovićCardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia.
Nebojša MarkovićCardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia.
Vera VučićevićCenter for Anesthesiology and Reanimatology, Clinical Center of Serbia, Belgrade, Serbia.
Gregory Y H LipCardiology Department, City Hospital, Birmingham, United Kingdom.
T Jared BunchIntermountain Medical Center Heart Institute, Intermountain Medical Center, Murray, Utah, United States.
Tatjana S PotparaCardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia.
Centar za Promociju Nauke · RSBirmingham City Hospital · GBCenter for Health, Exercise and Sport Sciences · RSPalo Alto University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early recurrence of atrial fibrillation (ERAF) after catheter-ablation (CA) can be a transient phenomenon due to inflammation, or a harbinger of late AF recurrence due to CA lesion (re)conduction. We studied the relationship between ERAF and the 3-month CA lesions integrity. Forty one consecutive AF patients who underwent a pulmonary vein isolation (PVI), roof line (RL) and mitral isthmus line (MIL) CA were enrolled. At 3 months all patients underwent invasive assessment of the lesion set integrity irrespective of ERAF. The PVI, RL and MIL ablation was successful in 100.0%, 95.1% and 82.9% patients, respectively. At the 3-month remapping, a gap in PVI-lesion(s), RL or MIL was identified in 61.0%, 31.7% and 36.6% patients, respectively. Patients with (n = 17, 41.5%) compared to those without ERAF (n = 24) had a significantly higher rate of any PV-reconnection (88.2% vs. 41.7%), the right PV(s)-reconnection (82.5% vs. 29.2%) and the RL gap (52.9% vs. 16.7%), as well as a higher number of reconnected right PVI-segments, all p < 0.05. On multivariate analysis, only the number of reconnected right PVI-segments was associated with ERAF (OR 4.26, p = 0.004). The ERAF following PVI + RL + MIL ablation was significantly related to 3-month PV-reconnections and the presence of RL gaps.

Indexed as

Catheter AblationAtrial FibrillationFemaleFollow-Up StudiesHumansMaleMiddle AgedRecurrenceTime FactorsTreatment Outcome

Identifiers

PMID29959347
PMCPMC6026210
OpenAlexW2810312393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.